10.21147/j.issn.1000-9604.2019.06.07
Efficacy of irinotecan-based chemotherapy after exposure to an anti-PD-1 antibody in patients with advanced esophageal squamous cell carcinoma
31
This study was partially supported by the Capital's Funds for Health Improvement and Research No.CFH2018-4-4024
2020-04-29(万方平台首次上网日期,不代表论文的发表时间)
共8页
910-917